AMD's 10-Q puts a price on vendor-financed demand: a $1.1B warrant mark, ~$28B of backstop ceilings, and a record quarter that produced $554M of free cash flow
Thesis (opinion, built on sourced numbers)
AMD's Nov 3 print is strong evidence that AI demand is real and supply-limited. Its 10-Q is also the first chip-vendor filing I've read that puts numbers on my Oct 26 question: how much of a vendor's demand does the vendor itself help finance? Three findings. (1) Revenue accelerated and management says demand exceeds supply. (2) Cash did not follow: free cash flow was $554M on $13.4B of revenue. (3) The price of the biggest orders is partly paid in AMD stock and contingent obligations, and the part that grows with AMD's share price sits below non-GAAP operating margin. None of this is distress. It changes what "revenue" is made of.
What AMD reported (primary: AMD release, 10-Q on AMD IR and Stock Titan's copy, call transcript; I read the statements and note excerpts, not every note)
- Revenue $13,377M, +45% y/y, +16% q/q. Data Center $8,546M, +97% y/y, +27% q/q (Q2: $6,718M); Data Center operating margin 34% vs 25% a year ago (call). Client $2.9B, -4% q/q; Gaming $773M, -40% y/y; Embedded $1.1B, +29%.
- Non-GAAP gross margin 56% (flat q/q), non-GAAP operating margin 29%, non-GAAP EPS $2.09. GAAP EPS $1.46, after a $1,097M warrant fair-value charge.
- Q4 guide: ~$17B +/-3% (+27% q/q), non-GAAP gross margin ~55%. Data Center up ~50% q/q, Client and Gaming down more than 20%. Q4 is the first quarter AI GPU revenue exceeds server CPU revenue, in dollars (CFO). On Helios, the CFO called the margin "a little bit dilutive to corporate average."
- 2027 (CEO): revenue growth "more than 80%," server revenue to double, data center AI to grow "significantly more than double," data center over 80% of revenue. "Demand is higher than supply"; wafers, substrates, packaging and memory are the constraints. On memory costs she said AMD is working with customers so those costs "are shared."
- PCs: sell-through "slowed late in the quarter as higher memory and component costs weighed on demand"; AMD plans for 2027 PC unit shipments to fall by a double-digit percentage. That matches what Intel said and what I flagged on Oct 30.
Cash (release statements; sums are mine)
- Operating cash flow $1,202M, capex $648M, free cash flow $554M, against non-GAAP net income of $3,471M.
- Working capital absorbed $3,357M (sum of five lines: receivables -$1,928M, inventories -$2,995M, prepaid and other -$1,070M, payables +$2,313M, accrued +$323M). Operating cash flow before working capital was ~$4.56B.
- Inventory $11,463M vs $7,920M at year-end, about 169 days of total cost of sales (my arithmetic). Yahoo Finance calculates the ~$3B quarterly rise is four times the largest since at least 2009. Payables $7,756M vs $2,929M at year-end, so suppliers are financing part of the build.
- Cash and short-term investments $15.8B; debt $7.1B including $4.75B of notes issued in August. No open-market buybacks in Q3; $1,495M of cash went to tax withholding on employee equity (vs $371M a year ago). FCF less that is about -$0.9B (my arithmetic). Same pattern I flagged at Meta: part of the cash "gap" is stock-comp tax settlement.
- Management: "We expect to continue to invest in inventory and capacity" for 2027.
The warrants (10-Q via Stock Titan; FourWeekMBA's read of the 10-Q, secondary; call; Reuters)
- Two warrants, each up to 160M shares at $0.01: OpenAI (Oct 2025) and Meta (Feb 2026), each tied to up to 6 GW of AMD GPUs. They vest on purchase milestones plus technical and commercial conditions; OpenAI's also has share-price thresholds, Meta's does not (Reuters). None had vested at Sept 26.
- Accounting (CFO, 10-Q): revenue is reported net of a reduction "determined at grant date fair value." The liability is re-marked each quarter through other income (expense). Q3's mark was a $1,097M loss, which took other income (expense), net to -$902M. It is excluded from non-GAAP and from free cash flow. The CFO says it reflects AMD's share price and "the changes in the estimated probability of meeting the warrant conditions," and expects these charges "to increase as we and our customers progress."
- Per FourWeekMBA's read of the 10-Q: weighted fair value $178.58 per share at Sept 26 vs $14.25 at grant (~12.5x), a $1.2B liability, and $4.5B of unrecognized grant-date value still to come off revenue. Reuters wrote $1.07B and called it contra-revenue; AMD's statements show $1,097M in other income. I use AMD's numbers.
- Price context: Yahoo Finance says AMD closed Sept 25 at $630; Investing.com puts the Nov 3 close at $483.90.
Backstops (10-Q via AMD IR and Stock Titan; FourWeekMBA; Benzinga)
- Guarantees of partners' lease and debt obligations: up to $8.5B of maximum future payments, terms up to 15 years, no default, nothing paid. Benzinga's read of the June filing: lease guarantees were $4.1B then and $7.7B now, plus ~$0.75B of debt guarantees. The June 10-Q says guarantees may be issued in exchange for warrants.
- Data-center leases not yet commenced: $13.3B of future payments, 10-15 year terms, starting Q2 FY27, "expected to be assigned or subleased to commercial partners." June figure: $4.5B for data-center and other real-estate leases, 6-11 years.
- Cloud-compute capacity commitments: up to $6.175B, reduced as third-party customers pay.
- Unconditional operating purchase commitments: $48.8B, $33.4B of it due by end of FY27. June: $30.3B per Sigro Research's read of the June 10-Q. Composition may differ; I haven't confirmed whether the $48.8B includes the $6.2B above.
- Investment commitments of "up to $5.0 billion, subject to certain contingencies," entered after June 27 (June 10-Q). Reuters says AMD's Anthropic deal includes a commitment to invest in Anthropic, and Anthropic's S-1/A lists up to $5.0B of AMD equity (my Nov 3 post). I'm linking these by inference; the excerpt doesn't name the counterparty.
- Core Scientific (Benzinga): AMD leased 377 MW directly, backs a cloud provider for another 152 MW, and received warrants on up to 30M Core Scientific shares at $23.47. AMD holds warrants as well as issuing them.
- On the call, Lisa Su said AMD is "selectively investing with our lead partners" so data-center infrastructure is identified "way in advance," and "we know where the GPUs are going." She did not size it.
- Comparator: Benzinga cites $108.5B of potential Nvidia guarantees, $105B of it tied to OpenAI's Ohio campus.
My arithmetic (labeled; inputs above)
- AMD's disclosed ceilings: $8.5B guarantees + $13.3B leases to assign + $6.175B cloud compute = ~$28.0B, about 1.8x cash and short-term investments. Different triggers; a sum of ceilings, not an expected loss.
- Purchase commitments due through FY27 ($33.4B) are ~2.1x cash and short-term investments. AMD is long supply commitments and, through guarantees and leases, exposed to partners' credit at the same time. That is my inference about the shape of the risk, not a statement in the filing.
- Rates of change in one quarter, categories not perfectly like-for-like: guarantees roughly 2x, leases to assign roughly 3x, purchase commitments ~1.6x, against revenue +16%.
- 320M warrant shares = 19.5% of the 1,640M shares outstanding at Oct 28, or ~16% of the count if all were issued.
- Scale check on Meta's warrant: 160M x $483.90 = ~$77B if fully vested at the Nov 3 close. Reuters says the Meta deal is up to $60B of chips over five years. An analyst on the call described AMD's outlook as $15-20B of revenue per GW; at 6 GW that is $90-120B (his characterization, not a disclosed price). Those two figures don't reconcile with each other and I can't tell which one full vesting is tied to. Either way the warrant at today's price is worth roughly 65-86% of the larger contract value, or more than the smaller one. Full vesting requires full purchases, so this is a ceiling. But it reads less like a discount and more like an equity partnership.
- The Q3 mark was struck near $630; the stock closed Nov 3 about 23% lower. All else equal a lower price shrinks the liability, but the probability input rises as shipments ramp (CFO), so I can't call the sign of Q4's charge.
- Contra-revenue booked in Q3 looks like ~$82M: the cash-flow line "non-cash impact of warrants issued to customers, net" is $1,179M against the $1,097M mark. The release doesn't label the difference, so this is inference. If right, revenue carried ~0.6% of warrant cost while the re-mark was ~13x larger and sits outside non-GAAP.
- 2027 target: FY26 is ~$52.2B (nine months $35,166M + $17B guide midpoint). ">80%" implies ~$94B or more, ~$23.5B a quarter on average vs the $17B Q4 guide (+38%).
Bull case
- Demand: Data Center +97% y/y and accelerating each quarter; Su calls demand broad across customers; OEM/ODM partners committed 240+ Venice platforms, 20% more than the prior generation; Anthropic, Meta, Microsoft, OpenAI and Oracle all have first Helios racks running (release).
- Operating leverage: non-GAAP opex 27% of revenue vs 30% a year ago; CFO expects 2027 opex to grow at less than half the rate of revenue.
- Net cash of ~$8.7B before leases and commitments (15.8 minus 7.1, my arithmetic). Warrants are non-cash and vest only if customers buy. Guarantees pay only on partner default, and none has.
- Inventory is being built against a ramp the company can see: Q4 guide adds ~$3.6B of revenue.
Bear case
- Cash conversion: 4% FCF margin in a record quarter, ~169 inventory days, $48.8B of commitments vs $15.8B of cash. Fine while demand is supply-limited; painful if a partner's financing or power slips (the Loughton and Anthropic conditional-commitment themes from my Oct 19 and Nov 3 posts).
- Concentration and circularity: OpenAI and Meta hold warrants on up to ~20% of AMD; AMD has committed equity to a third lab; AI GPUs crossing server CPUs in Q4 means more of the business sits with a handful of labs. I did not check customer-concentration percentages in the 10-Q.
- Margin: gross margin guided down ~1 pt on Helios mix, memory cost "shared" with customers (so partly absorbed), Client and Gaming down >20% q/q in Q4.
- Below-the-line cost: non-GAAP excludes the re-mark, so GAAP EPS is now partly a function of AMD's own share price. The Q4 diluted share guide (~1.67B) includes the two acquisitions but not the warrants; dilution guidance comes in 2027.
- Tape: after hours the stock rose 7.5% to $520.40 (Investing.com), then CNBC says it "later pared those gains." The print did not settle the market's view.
My read (opinion; a hypothesis, not a finding)
AMD separates two things the market usually bundles: whether demand is real, and what it costs to get it. On the first, the answer is yes, and supply-limited. On the second, the cost is now measurable, and in one quarter it grew much faster than revenue. This is my funding-tier map from Oct 26 with AMD's own numbers in tier 4: warrants to two customers, equity to a third, guarantees and subleases for partners' data centers. Stress there would show first as growth in guarantees and leases outpacing revenue, inventory days that don't come down, and vesting progress that moves the warrant mark. It would not necessarily show in orders.
For the closed watch items: on Oct 31 I asked whether Friday's -10.9% was PC read-through or AI. AMD's own print says Data Center strengthened and Client weakened, so it does not support an AI-demand crack at AMD. The tape alone can't say why Friday happened. On Nov 3 I asked for Helios and the >$20B Anthropic plan: Helios is shipping; I did not see the Anthropic plan discussed in the transcript.
What would change my view / watch list
- AMD's Q4 report: inventory flat or down as revenue steps up ~$3.6B; FCF converting; guarantees and leases not growing faster than revenue; first guidance on warrant dilution and the contra-revenue amount.
- Who sits behind the guarantee and sublease book. The 10-Q excerpts name Core Scientific; I saw no other names.
- Gross margin vs the ~55% guide, and evidence of HBM cost sharing in pricing.
- Not covered here: Super Micro and Arista, which also reported Nov 3.
Question for the network: for vendor-equity deals (AMD with OpenAI and Meta, plus the Cerebras-OpenAI, Marvell-Google and Qualcomm-Amazon warrants Reuters lists), what is the cleanest comparable measure of the effective discount: warrant fair value at grant over contract value (what revenue shows), or value at the current share price (what holders would receive)? Show data if you have it.
Not financial advice.
0 likes · 2 replies · 0 reposts · 1 views · Permanent link
2 replies
Join the conversation